Advertising & Promotion for Medical Products Conference

October 2026 | In-Person & Virtual Event

Overview

The Advertising and Promotion for Medical Products Conference convenes representatives from federal agencies, industry, patient advocacy groups, and academics to explore government initiatives and priorities concerning medical product advertising and promotion, critical developments in the field, trends in enforcement and regulation, and new technologies. Diverse perspectives, engagement opportunities, and timely subject matter make this a truly unique program with great learning potential. 

Register – Registration Date TBD

 

Call For Submissions

FDLI invites you to submit a proposal for a session for the Advertising and Promotion for Medical Products Conference. Your submissions and input are integral to ensuring that the most timely and pertinent topics are covered at the conference. Topics should address issues relating to marketing, advertising, and promotion as it impacts medical products regulation and policy in the United States.

The Call for Proposals will be open through March 16, 2026.

Proposal Submission Guidelines

  • Proposed topics should be at an advanced level.
  • Provide important details and context: why the topic is important, who is affected, and relevant regulatory, legislation, guidance, or newsworthy developments.
  • As a neutral convener, FDLI prefers topics that include multiple perspectives, including government, industry, private attorneys, academics, and public interest.
  • FDLI prefers submissions to include a reasonably detailed and thoughtful title for and description of the proposed session.

Submissions FAQ

  • Q: Am I limited in the number of proposals I can submit?
    • A: Multiple submissions from the same person or organization are welcome; however, each proposal requires its own form.
  • Q: How will my submission be reviewed?
    • A: All submissions are blinded before being reviewed by the Conference Planning Committee. All submissions are treated as recommendations, and proposals may be modified or combined by FDLI to best suit the needs of the conference.
  • Q: Do all items in my proposal need to be in final form?
    • A: No—Your proposal does not need to be in final form. A proposal can and will likely be updated by the Committee to include the newest or most up-to-date information as relevant for the FDLI audience.
  • Q: Should I reach out to speakers I suggest in advance of submitting my proposal?
    • A: Suggested speakers should not be invited in advance—sessions are often combined, and we cannot guarantee that suggested speakers will be included.
  • Q: Can I email you my submission?
    • A: All submissions must be received through the submission portal.
  • Q: If my topic is selected, do I get to speak? Do I have to speak if my topic is selected?
    • A: Speaking opportunities are generally reserved for FDLI members. If your topic is selected, you will be invited to speak if you are interested; however, speaking is not a requirement to submit a topic.
  • Q: How will I know if my submission is accepted?
    • A: You will be notified of the status of your submission approximately three months before the conference date.

Proposal Submission Timeline

  • March 16, 2026: Call for Proposals closes.
  • June 2026: Those who submitted proposals will be notified of their submission’s status.

 

Sponsors

Diamond

Gold

Silver

Sponsorship opportunities are available. Contact Cathy Scolieri for more information. View 2026 Sponsorship Opportunities

Planning Committee

Committee Members

Kelly Belnick, Johnson & Johnson
Dominick Paul DiSabatino, Sheppard Mullin Richter & Hampton LLP
Julie A. Dohm, Covington & Burling LLP
Kyle Y. Faget, Foley & Lardner LLP
Mark Gardner, Gardner Law, PLLC
Colleen M. Heisey, Jones Day
Alicia Kantor, Medtronic Vascular
Jae Kim, DLA Piper LLP (US)
Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
Alan G. Minsk, Arnall Golden Gregory LLP
Elizabeth Mulkey, Goodwin Procter LLP
Joshua M. Oyster, Ropes & Gray LLP
Lauren K. Roth, King & Spalding LLP
Jonathan Trinh, Arnold & Porter LLP
Carolina M. Wirth, Hall, Render, Killian, Heath & Lyman P.C.